Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900025765Phase 4Not yet recruiting
Phase 4, open-label, single-arm trial of roxadustat in Uraemic Anaemia, sponsored by Sichuan Provincial People's Hospital. Primary endpoint: major adverse cardiac events. Planned start Sep 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900025765.